TY - JOUR
T1 - ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization
AU - Tazelaar, Gijs H P
AU - Boeynaems, Steven
AU - De Decker, Mathias
AU - van Vugt, Joke J F A
AU - Kool, Lindy
AU - Goedee, H Stephan
AU - McLaughlin, Russell L
AU - Sproviero, William
AU - Iacoangeli, Alfredo
AU - Moisse, Matthieu
AU - Jacquemyn, Maarten
AU - Daelemans, Dirk
AU - Dekker, Annelot M
AU - van der Spek, Rick A
AU - Westeneng, Henk-Jan
AU - Kenna, Kevin P
AU - Assialioui, Abdelilah
AU - Da Silva, Nica
AU - Povedano, Mónica
AU - Pardina, Jesus S Mora
AU - Hardiman, Orla
AU - Salachas, François
AU - Millecamps, Stéphanie
AU - Vourc'h, Patrick
AU - Corcia, Philippe
AU - Couratier, Philippe
AU - Morrison, Karen E
AU - Shaw, Pamela J
AU - Shaw, Christopher E
AU - Pasterkamp, R Jeroen
AU - Landers, John E
AU - Van Den Bosch, Ludo
AU - Robberecht, Wim
AU - Al-Chalabi, Ammar
AU - van den Berg, Leonard H
AU - Van Damme, Philip
AU - Veldink, Jan H
AU - van Es, Michael A
N1 - © The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.
PY - 2020/5/19
Y1 - 2020/5/19
N2 - Increasingly, repeat expansions are being identified as part of the complex genetic architecture of amyotrophic lateral sclerosis. To date, several repeat expansions have been genetically associated with the disease: intronic repeat expansions in C9orf72, polyglutamine expansions in ATXN2 and polyalanine expansions in NIPA1. Together with previously published data, the identification of an amyotrophic lateral sclerosis patient with a family history of spinocerebellar ataxia type 1, caused by polyglutamine expansions in ATXN1, suggested a similar disease association for the repeat expansion in ATXN1. We, therefore, performed a large-scale international study in 11 700 individuals, in which we showed a significant association between intermediate ATXN1 repeat expansions and amyotrophic lateral sclerosis (P = 3.33 × 10-7). Subsequent functional experiments have shown that ATXN1 reduces the nucleocytoplasmic ratio of TDP-43 and enhances amyotrophic lateral sclerosis phenotypes in Drosophila, further emphasizing the role of polyglutamine repeat expansions in the pathophysiology of amyotrophic lateral sclerosis.
AB - Increasingly, repeat expansions are being identified as part of the complex genetic architecture of amyotrophic lateral sclerosis. To date, several repeat expansions have been genetically associated with the disease: intronic repeat expansions in C9orf72, polyglutamine expansions in ATXN2 and polyalanine expansions in NIPA1. Together with previously published data, the identification of an amyotrophic lateral sclerosis patient with a family history of spinocerebellar ataxia type 1, caused by polyglutamine expansions in ATXN1, suggested a similar disease association for the repeat expansion in ATXN1. We, therefore, performed a large-scale international study in 11 700 individuals, in which we showed a significant association between intermediate ATXN1 repeat expansions and amyotrophic lateral sclerosis (P = 3.33 × 10-7). Subsequent functional experiments have shown that ATXN1 reduces the nucleocytoplasmic ratio of TDP-43 and enhances amyotrophic lateral sclerosis phenotypes in Drosophila, further emphasizing the role of polyglutamine repeat expansions in the pathophysiology of amyotrophic lateral sclerosis.
U2 - 10.1093/braincomms/fcaa064
DO - 10.1093/braincomms/fcaa064
M3 - Article
C2 - 32954321
SN - 2632-1297
VL - 2
JO - Brain communications
JF - Brain communications
IS - 2
ER -